Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.8%

190 terminated/withdrawn out of 1128 trials

Success Rate

75.5%

-11.0% vs industry average

Late-Stage Pipeline

9%

102 trials in Phase 3/4

Results Transparency

49%

284 of 584 completed trials have results

Key Signals

194 recruiting284 with results124 terminated66 withdrawn

Enrollment Performance

Analytics

N/A
439(48.1%)
Phase 2
216(23.7%)
Phase 1
125(13.7%)
Phase 4
74(8.1%)
Early Phase 1
31(3.4%)
Phase 3
28(3.1%)
913Total
N/A(439)
Phase 2(216)
Phase 1(125)
Phase 4(74)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1128)

Showing 20 of 1128 trials
NCT06898996Recruiting

FITting Non-invasive Tests in Lynch Syndrome Surveillance

Role: lead

NCT07192055Not ApplicableRecruiting

Self-sampling to Optimize Anal Lesion Outcomes

Role: collaborator

NCT06382272Not ApplicableRecruiting

A Bionic Breast Project Using Neuroprosthesis to Reduce Chronic Pain After Mastectomy

Role: lead

NCT04254484Not ApplicableCompleted

SIESTA (Sleep of Inpatients: Empower Staff to Act) for Acute Stroke Rehabilitation

Role: lead

NCT06669572Phase 2Recruiting

Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment

Role: lead

NCT05624125Not ApplicableRecruiting

BEETroot Juice to Reverse Functional Impairment in PAD

Role: collaborator

NCT06837220Not ApplicableRecruiting

Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites

Role: lead

NCT07502365Not ApplicableNot Yet Recruiting

BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIV

Role: lead

NCT03500445Phase 2Active Not Recruiting

Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma

Role: lead

NCT03225820Recruiting

Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities

Role: lead

NCT06894199Recruiting

Work2Prevent Plus: Structural Intervention to Promote HIV Care in Black Sexual Minority Men

Role: lead

NCT03260387Active Not Recruiting

A Prospective Observational Study of TPIAT

Role: collaborator

NCT07211230Not Yet Recruiting

Collagenase Biobank Study

Role: lead

NCT04844359Active Not Recruiting

A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis

Role: collaborator

NCT05420948Phase 2Suspended

A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

Role: lead

NCT00961792Not ApplicableActive Not Recruiting

Chicago Social Drinking Project

Role: lead

NCT02216032Not ApplicableActive Not Recruiting

Thirty Million Words Home Visiting

Role: lead

NCT05723653Not ApplicableRecruiting

Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention

Role: lead

NCT07516652Not ApplicableRecruiting

Prospective Randomized Trial Comparing Longitudinal vs. Transverse A1 Pulley Release

Role: collaborator

NCT05515874Phase 4Completed

Predicting Stroke Risk in ICAD With Novel MRI

Role: collaborator